当前癌症患者诊断性超声心动图的建议:超声心动图是太晚还是太早?
癌症治疗相关心功能障碍可在治疗期间或治疗后任何时间出现。射血分数(尤其是三维技术)是评估左室收缩功能的既定基础值,形变成像能更准确敏感地检测亚临床左室收缩功能障碍,舒张功能参数不推荐用于筛查。是否调整肿瘤治疗或启动心脏治疗由心脏肿瘤多学科团队个体化决定。原文指出缺乏多中心研究和结局数据,尚不能回答超声心动图是太早还是太晚的问题。
要点
- 射血分数(尤其三维技术)是癌症治疗相关心功能障碍的既定基础评估值。
- 形变成像检测亚临床左室收缩功能障碍比射血分数更准确、更敏感。
- 舒张功能参数不推荐用于筛查。
核心结论
- 射血分数(尤其三维技术)是评估左室收缩功能、诊断癌症治疗相关心功能障碍的既定基础值。
- 形变成像分析左室功能是检测亚临床左室收缩功能障碍更准确、更敏感的工具。
- 舒张功能参数不推荐用于筛查。
- 发现左室功能障碍后是否调整肿瘤治疗和/或启动心脏治疗,由心脏肿瘤多学科专家团队结合预后与生活质量个体化决定。
- 缺乏多中心研究和结局数据,尚不能回答超声心动图是太早还是太晚的问题。
研究设计与样本
- 本文为Herz期刊的指南/共识类文章,原文未报告系统检索方法、证据分级及纳入文献情况。
- 原文未报告样本量、中心数及参考标准。
诊断标准与关键数值
- 射血分数(尤其三维技术)是癌症治疗相关心功能障碍的既定基础评估值。
- 形变成像分析左室功能是检测亚临床左室收缩功能障碍更准确、更敏感的工具。
- 舒张功能参数不推荐用于筛查。
- 各专科协会对标准化随访检查频率和标准化超声心动图参数的建议存在差异。
临床应用与阅片要点
- 广泛共识认为这类患者应在具备适当设备和诊断专长的超声心动图实验室接受检查。
- 发现左室功能障碍后是否调整肿瘤治疗和/或启动心脏治疗,由心脏肿瘤多学科专家团队结合预后与生活质量个体化决定。
- 尽管已知心脏毒性治疗增加发病率和死亡率,但接受适当检查的患者太少。
局限性
- 缺乏多中心研究。
- 结局数据匮乏,尚不能回答超声心动图是太早还是太晚的问题。
- 各专科协会对标准化随访检查频率和标准化超声心动图参数的建议存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cardiac dysfunction caused by cardiotoxic treatment can appear at any time during or after therapy and sometimes even after years. To evaluate systolic left ventricular (LV) function assessment of the ejection fraction (EF), especially using 3D technology, is the established base value for cancer therapy-related cardiac dysfunction (CTRCD). It has been found that additional analysis of the LV function using deformation imaging is a more accurate and sensitive tool for detecting subclinical systolic LV dysfunction. Diastolic function parameters are not recommended for screening. The decision to modify oncological treatment and/or to begin specific cardiac treatment after detecting LV dysfunction is based on known data taking both the prognosis and quality of life into consideration and performed in individual cases by a cardio-oncological team of experts. There is a widely held consensus that these patients should be examined in an echocardiographic laboratory which has the appropriate equipment and diagnostic expertise. The lack of multicenter studies and the paucity of outcome data do not yet answer the question if echocardiography is carried out too early or too late. Recommendations on the frequency of standardized follow-up examinations and standardized echocardiographic parameter vary between the specialist societies. Although increased morbidity and mortality due to cardiotoxic treatment are now well known facts, too few patients undergo appropriate examinations.
引用
- Kruck I. [Current recommendations for diagnostic echocardiography in cancer patients : Is echocardiography too late or too early?]. Herz. 2017. PMID: 28233035. doi:10.1007/s00059-017-4542-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。